title: Influenza vaccination: the persuasiveness of messages among people aged 65 years and older.
abstract: About 90% of all influenza-related deaths occur among people aged 65 years and older. Vaccination remains the primary option for preventing influenza infection. This study examined the efficacy of messages designed to increase the uptake of influenza vaccination. Two messages, narrative and didactic, were created based on the Extended Parallel Process Model (EPPM). The study employed a one-factor between-subjects experimental design with participants assigned randomly to three conditions: no message, didactic communication, and narrative communication. Participants were 311 Italian people aged 65 years or older. The results showed that, compared to no message and didactic communication, narrative communication was related to higher risk perception of influenza, to higher perception of the efficacy of the vaccine, and to self-efficacy related to vaccination, controlling for social trust, previous flu shot, and demographic variables. There were no differences among the three conditions with respect to the intention to receive the influenza vaccine. Findings suggest that narrative communication based on EPPM may have a persuasive effect on people aged 65 years or older.
authors.affiliation: Department of Education Sciences, University of Bologna, Italy. gabriele.prati@unibo.it
authors.forename: Gabriele
authors.initials: G
authors.lastname: Prati
authors.forename: Luca
authors.initials: L
authors.lastname: Pietrantoni
authors.forename: Bruna
authors.initials: B
authors.lastname: Zani
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005239:Fear; D005260:Female; D058015:Health Communication / Q000379:methods*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D018570:Risk Assessment; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D007252:Influenza Vaccines